Story perspectives
First Patient Walks After Groundbreaking CRISPR Therapy
12/19/2025
1 of 1
Story summary
- KJ Muldoon, treated with a personalized CRISPR therapy at Children's Hospital of Philadelphia, has taken his first steps.
- KJ became the first patient to receive this CPS1-deficiency therapy developed by Dr. Rebecca Ahrens-Nicklas and Dr. Kiran Musunuru.
- After ten months in the hospital, he was discharged in June and celebrated his first birthday at home.
- KJ's case is prompting discussions on new models for approving personalized therapies for rare diseases.
